{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:18:41Z","timestamp":1783041521090,"version":"3.54.6"},"reference-count":88,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T00:00:00Z","timestamp":1779148800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["R21AI153976"],"award-info":[{"award-number":["R21AI153976"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006444","name":"Center for Excellence in Regulatory Science and Innovation, University of Maryland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006444","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.virol.2026.110960","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T23:18:40Z","timestamp":1779232720000},"page":"110960","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Towards the development of a mucosal vectored vaccine against enterovirus D68"],"prefix":"10.1016","volume":"621","author":[{"given":"Anna","family":"Zimina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina G.","family":"Viktorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kouiavskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Chumakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy B.","family":"Rosenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0892-1731","authenticated-orcid":false,"given":"George A.","family":"Belov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.virol.2026.110960_bib1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.molmet.2015.03.001","article-title":"Integration of body temperature into the analysis of energy expenditure in the mouse","volume":"4","author":"Abreu-Vieira","year":"2015","journal-title":"Mol. Metabol."},{"key":"10.1016\/j.virol.2026.110960_bib2","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.01586-16","article-title":"Increasing type 1 poliovirus capsid stability by thermal selection","volume":"91","author":"Adeyemi","year":"2017","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib3","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1619","article-title":"Acute flaccid myelitis in the United States: 2015-2017","volume":"144","author":"Ayers","year":"2019","journal-title":"Pediatrics"},{"key":"10.1016\/j.virol.2026.110960_bib4","doi-asserted-by":"crossref","first-page":"7188","DOI":"10.1016\/j.vaccine.2011.05.079","article-title":"Inactivated polio vaccine development for technology transfer using attenuated sabin poliovirus strains to shift from Salk-IPV to Sabin-IPV","volume":"29","author":"Bakker","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110960_bib5","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1006\/viro.1999.0043","article-title":"Poliovirus protease 3C(pro) kills cells by apoptosis","volume":"266","author":"Barco","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.110960_bib6","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/pro.5560031005","article-title":"Role and mechanism of the maturation cleavage of VP0 in poliovirus assembly: structure of the empty capsid assembly intermediate at 2.9 A resolution","volume":"3","author":"Basavappa","year":"1994","journal-title":"Protein Sci."},{"key":"10.1016\/j.virol.2026.110960_bib7","doi-asserted-by":"crossref","first-page":"4218","DOI":"10.1128\/JCM.40.11.4218-4223.2002","article-title":"Human rhinovirus 87 and enterovirus 68 represent a unique serotype with rhinovirus and enterovirus features","volume":"40","author":"Blomqvist","year":"2002","journal-title":"J. Clin. Microbiol."},{"key":"10.1016\/j.virol.2026.110960_bib8","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01954-18","article-title":"Contemporary circulating enterovirus D68 strains have acquired the capacity for viral entry and replication in human neuronal cells","volume":"9","author":"Brown","year":"2018","journal-title":"mBio"},{"key":"10.1016\/j.virol.2026.110960_bib9","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1007\/s00705-017-3459-1","article-title":"Evaluation of the replication and pathogenicity of a variant avian paramyxovirus serotype 6 in mice","volume":"162","author":"Bui","year":"2017","journal-title":"Arch. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib10","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.3389\/fmicb.2018.02677","article-title":"Enterovirus D68 - the new polio?","volume":"9","author":"Cassidy","year":"2018","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2026.110960_bib11","first-page":"303","article-title":"Newcastle disease virus antibodies in human sera","volume":"73","author":"Charan","year":"1981","journal-title":"Indian J. Med. Res."},{"key":"10.1016\/j.virol.2026.110960_bib12","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/s42003-025-08253-y","article-title":"Structural insights from vaccine candidates for EV-D68","volume":"8","author":"Cheng","year":"2025","journal-title":"Commun. Biol."},{"key":"10.1016\/j.virol.2026.110960_bib13","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.vaccine.2017.12.057","article-title":"A virus-like particle vaccine confers protection against enterovirus D68 lethal challenge in mice","volume":"36","author":"Dai","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110960_bib14","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001851","article-title":"Emergence of biased hypermutation in a heterologous additional transcription unit in recombinant lentogenic Newcastle disease virus","volume":"104","author":"de Buhr","year":"2023","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/j.coviro.2023.101348","article-title":"Advantages and challenges of Newcastle disease virus as a vector for respiratory mucosal vaccines","volume":"62","author":"de Swart","year":"2023","journal-title":"Curr. Opin. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib16","doi-asserted-by":"crossref","first-page":"9788","DOI":"10.1073\/pnas.0703584104","article-title":"Newcastle disease virus, a host range-restricted virus, as a vaccine vector for intranasal immunization against emerging pathogens","volume":"104","author":"DiNapoli","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2026.110960_bib17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1128\/JVI.01946-09","article-title":"Newcastle disease virus-vectored vaccines expressing the hemagglutinin or neuraminidase protein of H5N1 highly pathogenic Avian influenza virus protect against virus challenge in monkeys","volume":"84","author":"DiNapoli","year":"2010","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib18","doi-asserted-by":"crossref","first-page":"11560","DOI":"10.1128\/JVI.00713-07","article-title":"Immunization of primates with a Newcastle disease virus-vectored vaccine via the respiratory tract induces a high titer of serum neutralizing antibodies against highly pathogenic avian influenza virus","volume":"81","author":"DiNapoli","year":"2007","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib19","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2022.2149352","article-title":"Non-neutralizing monoclonal antibody targeting VP2 EF loop of Coxsackievirus A16 can protect mice from lethal attack via Fc-dependent effector mechanism","volume":"12","author":"Du","year":"2023","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virol.2026.110960_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2017.00257","article-title":"Global distribution and evolutionary history of Enterovirus D68, with emphasis on the 2014 outbreak in Ontario, Canada","volume":"8","author":"Eshaghi","year":"2017","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2026.110960_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1006117","article-title":"Genetically Thermo-stabilised, immunogenic poliovirus empty capsids; a strategy for non-replicating vaccines","volume":"13","author":"Fox","year":"2017","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2026.110960_bib22","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.ymthe.2005.08.016","article-title":"Phase I\/II trial of intravenous NDV-HUJ oncolytic virus in recurrent glioblastoma multiforme","volume":"13","author":"Freeman","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.virol.2026.110960_bib23","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.66687","article-title":"Respiratory and intestinal epithelial cells exhibit differential susceptibility and innate immune responses to contemporary EV-D68 isolates","volume":"10","author":"Freeman","year":"2021","journal-title":"eLife"},{"key":"10.1016\/j.virol.2026.110960_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/S1473-3099(15)70093-9","article-title":"A novel outbreak enterovirus D68 strain associated with acute flaccid myelitis cases in the USA (2012-14): a retrospective cohort study","volume":"15","author":"Greninger","year":"2015","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.virol.2026.110960_bib25","doi-asserted-by":"crossref","first-page":"4121","DOI":"10.1093\/bioinformatics\/bty407","article-title":"Nextstrain: real-time tracking of pathogen evolution","volume":"34","author":"Hadfield","year":"2018","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2026.110960_bib26","doi-asserted-by":"crossref","first-page":"585","DOI":"10.3201\/eid2503.180960","article-title":"Neutralizing antibody against enterovirus D68 in children and adults before 2014 outbreak, Kansas City, Missouri, USA","volume":"25","author":"Harrison","year":"2019","journal-title":"Emerg. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110960_bib27","doi-asserted-by":"crossref","first-page":"2835","DOI":"10.1007\/s11033-020-05333-6","article-title":"Characterization of Coxsackievirus B4 virus-like particles VLP produced by the recombinant baculovirus-insect cell system expressing the major capsid protein","volume":"47","author":"Hassine","year":"2020","journal-title":"Mol. Biol. Rep."},{"key":"10.1016\/j.virol.2026.110960_bib28","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1007\/s00431-019-03435-3","article-title":"Acute flaccid myelitis and enterovirus D68: lessons from the past and present","volume":"178","author":"Helfferich","year":"2019","journal-title":"Eur. J. Pediatr."},{"key":"10.1016\/j.virol.2026.110960_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1010515","article-title":"Evolution, geographic spreading, and demographic distribution of Enterovirus D68","volume":"18","author":"Hodcroft","year":"2022","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.virol.2026.110960_bib30","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2105\/AJPH.38.9.1263","article-title":"Presence of neutralizing antibodies of Newcastle disease virus in human sera","volume":"38","author":"Howitt","year":"1948","journal-title":"Am. J. Public Health Nation's Health"},{"key":"10.1016\/j.virol.2026.110960_bib31","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1099\/0022-1317-82-7-1729","article-title":"High-level expression of a foreign gene from the most 3'-proximal locus of a recombinant Newcastle disease virus","volume":"82","author":"Huang","year":"2001","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib32","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/0042-6822(62)90205-2","article-title":"Identification of poliovirus particles of different antigenicity by specific agglutination as seen in the electron microscope","volume":"16","author":"Hummeler","year":"1962","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.110960_bib34","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2807\/1560-7917.ES.2019.24.35.1800671","article-title":"Enterovirus D68 serosurvey: evidence for endemic circulation in the Netherlands, 2006 to 2016","volume":"24","author":"Karelehto","year":"2019","journal-title":"Euro Surveill."},{"key":"10.1016\/j.virol.2026.110960_bib35","article-title":"Update on acute flaccid myelitis in the United States","volume":"68","author":"Kaye","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110960_bib36","first-page":"1","article-title":"Enterovirus surveillance--United States, 1970-2005","volume":"55","author":"Khetsuriani","year":"2006","journal-title":"MMWR Surveill Summ"},{"key":"10.1016\/j.virol.2026.110960_bib37","volume":"vol. 8","author":"Kim","year":"2016"},{"key":"10.1016\/j.virol.2026.110960_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/v8070183","article-title":"Newcastle disease virus as a vaccine vector for development of human and veterinary vaccines","volume":"8","author":"Kim","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.110960_bib39","doi-asserted-by":"crossref","DOI":"10.1099\/jgv.0.001771","article-title":"Thermal stabilization of enterovirus A 71 and production of antigenically stabilized empty capsids","volume":"103","author":"Kingston","year":"2022","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib33","series-title":"Beitrag Zur Kollektiven Behandlung Pharmakologischer Reihenversuche","first-page":"480","author":"K\u00e4rber","year":"1931"},{"key":"10.1016\/j.virol.2026.110960_bib40","doi-asserted-by":"crossref","first-page":"793","DOI":"10.5858\/2010-0174-CR.1","article-title":"A fatal central nervous system enterovirus 68 infection","volume":"135","author":"Kreuter","year":"2011","journal-title":"Arch. Pathol. Lab Med."},{"key":"10.1016\/j.virol.2026.110960_bib41","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.adg6076","article-title":"EV-D68 virus-like particle vaccines elicit cross-clade neutralizing antibodies that inhibit infection and block dissemination","volume":"9","author":"Krug","year":"2023","journal-title":"Sci. Adv."},{"key":"10.1016\/j.virol.2026.110960_bib42","series-title":"Fields Virology","first-page":"1449","article-title":"Paramyxoviridae: the viruses and their replication","author":"Lamb","year":"2007"},{"key":"10.1016\/j.virol.2026.110960_bib43","doi-asserted-by":"crossref","first-page":"6642","DOI":"10.1016\/j.vaccine.2012.08.071","article-title":"A virus-like particle vaccine for coxsackievirus A16 potently elicits neutralizing antibodies that protect mice against lethal challenge","volume":"30","author":"Liu","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110960_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2024.126511","article-title":"Phase II study on the safety and immunogenicity of single-dose intramuscular or intranasal administration of the AVX\/COVID-12 \"Patria\" recombinant Newcastle disease virus vaccine as a heterologous booster against COVID-19 in Mexico","volume":"43","author":"Lopez-Macias","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110960_bib45","author":"L\u00f3pez-Mac\u00edas","year":"2024","journal-title":"medRxiv, 2024.2002.2011.24302530"},{"key":"10.1016\/j.virol.2026.110960_bib46","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2147\/BTT.S140114","article-title":"New frontiers in oncolytic viruses: optimizing and selecting for virus strains with improved efficacy","volume":"12","author":"Lundstrom","year":"2018","journal-title":"Biol. Targets & Ther."},{"key":"10.1016\/j.virol.2026.110960_bib47","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/0042-6822(67)90045-1","article-title":"Composition of artificially produced and naturally occurring empty capsids of poliovirus type 1","volume":"32","author":"Maizel","year":"1967","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.110960_bib48","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-2600(15)00335-5","article-title":"Severe respiratory illness associated with a nationwide outbreak of enterovirus D68 in the USA (2014): a descriptive epidemiological investigation","volume":"3","author":"Midgley","year":"2015","journal-title":"Lancet Respir. Med."},{"key":"10.1016\/j.virol.2026.110960_bib49","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.4161\/21645515.2014.981115","article-title":"The polio endgame","volume":"10","author":"Minor","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"issue":"Pt 7","key":"10.1016\/j.virol.2026.110960_bib50","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1099\/0022-1317-67-7-1283","article-title":"Antigenic structure of polioviruses of serotypes 1, 2 and 3","volume":"67","author":"Minor","year":"1986","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib51","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/301674a0","article-title":"Location and primary structure of a major antigenic site for poliovirus neutralization","volume":"301","author":"Minor","year":"1983","journal-title":"Nature"},{"key":"10.1016\/j.virol.2026.110960_bib52","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.00521-19","article-title":"Acute flaccid myelitis: something old and something new","volume":"10","author":"Morens","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.virol.2026.110960_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/v17050673","article-title":"Return of the biennial circulation of enterovirus D68 in Colorado children in 2024 following the large 2022 outbreak","volume":"17","author":"Nguyen-Tran","year":"2025","journal-title":"Viruses"},{"key":"10.1016\/j.virol.2026.110960_bib54","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1099\/vir.0.79925-0","article-title":"Enterovirus 68 is associated with respiratory illness and shares biological features with both the enteroviruses and the rhinoviruses","volume":"85","author":"Oberste","year":"2004","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib55","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1016\/S0140-6736(23)02844-1","article-title":"Safety of the novel oral poliovirus vaccine type 2 (nOPV2) in infants and young children aged 1 to <5 years and lot-to-lot consistency of the immune response to nOPV2 in infants in the Gambia: a phase 3, double-blind, randomised controlled trial","volume":"403","author":"Ochoge","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/j.virol.2026.110960_bib56","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.1128\/jvi.62.5.1781-1794.1988","article-title":"Three-dimensional structure of poliovirus serotype 1 neutralizing determinants","volume":"62","author":"Page","year":"1988","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib57","doi-asserted-by":"crossref","first-page":"9522","DOI":"10.1128\/JVI.77.17.9522-9532.2003","article-title":"Newcastle disease virus V protein is a determinant of host range restriction","volume":"77","author":"Park","year":"2003","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib58","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166336","article-title":"Enterovirus D-68 infection, prophylaxis, and vaccination in a novel permissive animal model, the cotton rat (Sigmodon hispidus)","volume":"11","author":"Patel","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.virol.2026.110960_bib59","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1017\/S095026880004752X","article-title":"Detection of antibody to avian viruses in human populations","volume":"104","author":"Pedersden","year":"1990","journal-title":"Epidemiol. Infect."},{"key":"10.1016\/j.virol.2026.110960_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jcv.2015.07.296","article-title":"European surveillance for enterovirus D68 during the emerging North-American outbreak in 2014","volume":"71","author":"Poelman","year":"2015","journal-title":"J. Clin. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib61","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41541-023-00662-6","article-title":"Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico","volume":"8","author":"Ponce-de-Leon","year":"2023","journal-title":"NPJ Vaccines"},{"key":"10.1016\/j.virol.2026.110960_bib62","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1128\/jvi.40.1.173-183.1981","article-title":"Differences between poliovirus empty capsids formed in vivo and those formed in vitro: a role for the morphopoietic factor","volume":"40","author":"Putnak","year":"1981","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib63","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1128\/mr.45.2.287-315.1981","article-title":"Picornaviral structure and assembly","volume":"45","author":"Putnak","year":"1981","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.virol.2026.110960_bib64","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.1016\/j.vaccine.2016.02.077","article-title":"Status of research and development of vaccines for enterovirus 71","volume":"34","author":"Reed","year":"2016","journal-title":"Vaccine"},{"issue":"Pt 8","key":"10.1016\/j.virol.2026.110960_bib65","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1099\/0022-1317-78-8-1829","article-title":"Immunogenic, non-infectious polio subviral particles synthesized in Saccharomyces cerevisiae","volume":"78","author":"Rombaut","year":"1997","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib66","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.02370-19","article-title":"Neurotropism of Enterovirus D68 isolates is independent of sialic acid and is not a recently acquired phenotype","volume":"10","author":"Rosenfeld","year":"2019","journal-title":"mBio"},{"key":"10.1016\/j.virol.2026.110960_bib67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1297-9716-42-38","article-title":"Experimental infection of hamsters with avian paramyxovirus serotypes 1 to 9","volume":"42","author":"Samuel","year":"2011","journal-title":"Vet. Res."},{"key":"10.1016\/j.virol.2026.110960_bib68","doi-asserted-by":"crossref","DOI":"10.1093\/oxfordjournals.aje.a120693","article-title":"A probable new human picornavirus associated with respiratory disease","volume":"85","author":"Schieble","year":"1967","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.virol.2026.110960_bib69","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines4030016","article-title":"Fifty years of clinical application of Newcastle disease virus: time to celebrate","volume":"4","author":"Schirrmacher","year":"2016","journal-title":"Biomedicines"},{"key":"10.1016\/j.virol.2026.110960_bib70","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/cid\/ciw372","article-title":"Acute flaccid myelitis in the United States, August-December 2014: results of nationwide surveillance","volume":"63","author":"Sejvar","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.virol.2026.110960_bib71","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1038\/s41467-025-56118-z","article-title":"Recombinant expression systems for production of stabilised virus-like particles as next-generation polio vaccines","volume":"16","author":"Sherry","year":"2025","journal-title":"Nat. Commun."},{"key":"10.1016\/j.virol.2026.110960_bib72","doi-asserted-by":"crossref","DOI":"10.1128\/spectrum.04300-22","article-title":"Protease-Independent production of poliovirus virus-like particles in pichia pastoris: implications for efficient vaccine development and insights into capsid assembly","volume":"11","author":"Sherry","year":"2023","journal-title":"Microbiol. Spectr."},{"key":"10.1016\/j.virol.2026.110960_bib73","doi-asserted-by":"crossref","first-page":"11","DOI":"10.2807\/1560-7917.ES.2015.20.43.30047","article-title":"Systematic community- and hospital-based surveillance for enterovirus-D68 in three Canadian provinces, August to December 2014","volume":"20","author":"Skowronski","year":"2015","journal-title":"Euro Surveill."},{"key":"10.1016\/j.virol.2026.110960_bib74","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.antiviral.2018.11.013","article-title":"A neonatal mouse model of Enterovirus D68 infection induces both interstitial pneumonia and acute flaccid myelitis","volume":"161","author":"Sun","year":"2019","journal-title":"Antivir. Res."},{"key":"10.1016\/j.virol.2026.110960_bib75","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1099\/vir.0.043935-0","article-title":"Worldwide emergence of multiple clades of enterovirus 68","volume":"93","author":"Tokarz","year":"2012","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib76","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1637\/11512-100616-RegR1","article-title":"Recombinant Avian paramyxovirus serotypes 2, 6, and 10 as vaccine vectors for highly pathogenic Avian influenza in chickens with antibodies against Newcastle disease virus","volume":"61","author":"Tsunekuni","year":"2017","journal-title":"Avian Dis."},{"issue":"Pt 6","key":"10.1016\/j.virol.2026.110960_bib77","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1099\/0022-1317-70-6-1453","article-title":"Synthesis of immunogenic, but non-infectious, poliovirus particles in insect cells by a baculovirus expression vector","volume":"70","author":"Urakawa","year":"1989","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib78","doi-asserted-by":"crossref","first-page":"8285","DOI":"10.1158\/0008-5472.CAN-07-1025","article-title":"Use of reverse genetics to enhance the oncolytic properties of newcastle disease virus","volume":"67","author":"Vigil","year":"2007","journal-title":"Cancer Res."},{"key":"10.1016\/j.virol.2026.110960_bib79","doi-asserted-by":"crossref","DOI":"10.1128\/JVI.00976-18","article-title":"Newcastle disease virus-based vectored vaccine against poliomyelitis","volume":"92","author":"Viktorova","year":"2018","journal-title":"J. Virol."},{"key":"10.1016\/j.virol.2026.110960_bib80","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aba4902","article-title":"Human antibodies neutralize enterovirus D68 and protect against infection and paralytic disease","volume":"5","author":"Vogt","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.virol.2026.110960_bib81","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1056\/NEJMc2118155","article-title":"Enterovirus D68 in the anterior horn cells of a child with acute flaccid myelitis","volume":"386","author":"Vogt","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.virol.2026.110960_bib82","series-title":"Manual for the Virological Investigation of Polio. Global Programme for Vaccines and Immunization, Expanded Programme on Immunization","author":"Who","year":"1997"},{"key":"10.1016\/j.virol.2026.110960_bib83","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1006\/viro.1995.1332","article-title":"Replication-deficient vaccinia virus encoding bacteriophage T7 RNA polymerase for transient gene expression in mammalian cells","volume":"210","author":"Wyatt","year":"1995","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.110960_bib84","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/0042-6822(88)90172-9","article-title":"Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor","volume":"166","author":"Ypma-Wong","year":"1988","journal-title":"Virology"},{"key":"10.1016\/j.virol.2026.110960_bib85","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41426-017-0005-x","article-title":"Enterovirus D68 virus-like particles expressed in Pichia pastoris potently induce neutralizing antibody responses and confer protection against lethal viral infection in mice","volume":"7","author":"Zhang","year":"2018","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.virol.2026.110960_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/v10020058","article-title":"A mouse model of Enterovirus D68 infection for assessment of the efficacy of inactivated vaccine","volume":"10","author":"Zhang","year":"2018","journal-title":"Viruses-Basel"},{"key":"10.1016\/j.virol.2026.110960_bib87","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1016\/j.vaccine.2012.01.061","article-title":"Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis","volume":"30","author":"Zhang","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110960_bib88","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.jcv.2015.06.086","article-title":"Neutralization of enterovirus D68 isolated from the 2014 US outbreak by commercial intravenous immune globulin products","volume":"69","author":"Zhang","year":"2015","journal-title":"J. Clin. Virol."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:46:46Z","timestamp":1783039606000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226001753"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":88,"alternative-id":["S0042682226001753"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.110960","relation":{"has-preprint":[{"id-type":"doi","id":"10.64898\/2025.12.12.693937","asserted-by":"object"}]},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards the development of a mucosal vectored vaccine against enterovirus D68","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.110960","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"110960"}}